Division of Cardiovascular Medicine
Welcome to the Division of Cardiovascular Medicine. Our Division comprises both clinical and non-clinical academics, NHS cardiologists, postdoctoral scientists, technicians and administrators who work together to conduct research and to engage in service delivery. We also provide teaching to young doctors in training, medical students and students registered for higher degrees.
The Division has an international history of clinical trials in patients with a wide range of cardiovascular problems. Current clinical research activity centres on trials of novel anti-platelet and anti-thrombotic drugs for acute ischaemic coronary syndromes and a comparison of pre-hospital delivery of thrombolysis with direct transfer for primary coronary artery angioplasty. We also have a reputation for high quality epidemiology and health sciences research in the fields of myocardial infarction and health economics. Our clinical academic members work closely with their NHS colleagues at both the City Hospital and University Hospital sites, and with colleagues involved in basic research.
For many years the Division’s programme of basic research has been aimed at understanding the mechanisms involved in cardiovascular disease and at improving diagnosis and treatment. Much of this work is performed via the Thrombosis and Haemostasis Research Group which has a focus on the contribution of platelets and other blood cells to these pathological and physiological processes. Outcomes have contributed to publications, teaching and also translational research, which culminated recently in the award of a DPFS/MRC grant, and in commercial activity via Platelet Solutions, an embedded unit that offers services to enhance healthcare.
The Division is located in purpose-built accommodation at the Queens Medical Centre and comprises offices and well-equipped laboratories that are in close proximity to wards and other clinical facilities.
Acting Head of Division: Professor Philip Bath
News & Events
News
- Description
- Mr David Richens appointed as Honorary Clinical Associate Professor.
- Date:
- 17/11/2011
- Description
- A model system based on technology that allows skin cells to be converted into stem cells, and subsequently heart cells, may provide a new way to evaluate drugs in treating Long QT Syndrome, a genetic heart disorder, according to research led by Professor Chris Denning published in the European Heart Journal.
- Date:
- 26/10/2011
Events
There are no results that match your criteria.
See all News & Events